Alzheimer’s Strategic Fund: Neuroimmune Program

The Alzheimer’s Strategic Fund, established in 2019, will support innovative, high risk, team science opportunities that investigate and focus on outstanding questions related to the biological underpinnings of Alzheimer’s disease.

 The A Fund is targeted to address gaps in our understanding of how immune responses may impact AD and AD-related disorders.

Priority will be given to studies that leverage interdisciplinary and/or inter-institutional teams to accomplish the proposed project in a way no one group would be able to do independently.

Funding: $300,000 total 

Duration: 3 years 

Research Authority due date: 13.8.20

LOI (required) due date: 20.8.20

Full proposal due date: five (5) weeks from the date of invitation to submit.